- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 93,820 | 12.07.24 14:33:20 | +0,020 | +0,02% | 94,130 | 94,180 | 94,510 | 93,800 |
|
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 996,000 | 12.07.24 13:43:54 | +13,600 | +1,38% | 992,000 | 998,000 | 989,400 | 982,400 |
